Exelixis, Inc.

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…

Biotechnology

US, Alameda [HQ]

Overview
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More

Lobbying · US Senate · Influence

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Exelixis, Inc. to fulfill lobbying activities in the United States of America.

FY	Quarter	Lobby Expense [in mil. $]	Filing	Report Time
2024	3	5	LDA-2	Oct. 21, 2024, 11:19 a.m.
2024	3	6	LDA-2	Oct. 18, 2024, 4:59 p.m.
2024	2	5	LDA-2	July 19, 2024, 4:01 a.m.
2024	2	6	LDA-2	July 18, 2024, 5:09 p.m.
2024	1	5	LDA-2	April 23, 2024, 2:39 a.m.
2024	1	6	LDA-2	April 22, 2024, 3:20 p.m.
2023	4	5	LDA-2	Jan. 23, 2024, 3:23 a.m.
2023	4	6	LDA-2	Jan. 19, 2024, 5:49 p.m.
2023	4	6	LDA-2	Jan. 18, 2024, 8:05 p.m.